Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(28 sites)
United States
East Valley Urology Center of Arizona, Mesa, Arizona Arkansas Urology Research Center, Little Rock, Arkansas UC Irvine, Irvine, California Comprehensive Urology Medical Group, Los Angeles, California Alarcon Urology Center, Montebello, California University of Florida Health- Jacksonville, Jacksonville, Florida Biogenix Molecular, Miami, Florida Endeavor Health- Glenbrook Hospital, Glenview, Illinois Indiana University Health-IU Simon Cancer Center, Indianapolis, Indiana Wichita Urology Group, Wichita, Kansas XCancer Research Network / LCMC Health EJGH, Metairie, Louisiana M. Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota St. Louis University, St Louis, Missouri New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico Albany Medical College, Albany, New York University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Carolina Urologic Research Center, Myrtle Beach, South Carolina Urology Associates, P.C., Nashville, Tennessee Urology Clinics of North Texas, Dallas, Texas Houston Metro Urology-SW, Houston, Texas The Urology Place, San Antonio, Texas Summit Urology, Murray, Utah Intermountain Medical Center, Salt Lake City, Utah Australia
St. Vincent's Hospital, Sydney, Darlinghurst, New South Wales Sydney Adventist Hospital, Wahroonga, New South Wales Westmead Private Hosptial, Westmead, New South Wales Royal Brisbane and Women's Hospital, Herston, Queensland